Exclusive: Opioid crisis cost Georgia $81 billion last year
Opioid abuse is as much an economic problem as a public health one, according to a comprehensive analysis provided first to Axios that shows Georgia spends more than $730,000 on each such case.
Why it matters: The cost burden falls unevenly across the country, with states in a belt stretching through Appalachia to New England typically having bigger caseloads and a higher cost per case.
Context: Opioid use disorder — defined as frequent opioid use and unsuccessful efforts to quit — is estimated to affect more than 6 million people in the United States, costing the nation an estimated $4 trillion last year, per health care consulting firm Avalere Health.
The cumulative economic burden on patients, including years of life lost and reduced quality of life, exceeded $3 trillion in 2024, Avalere estimated.
Context: At $736,361, Georgia's average cost per case is slightly higher than the national average, per the analysis from Avalere, which used 2017 figures to project 2024 net costs.
Zoom out: In Georgia, patients bore more than $62.1 billion in costs from reduced quality of life and statistical loss of life.
Businesses absorbed more than $9.6 billion in costs from lost productivity and health insurance costs.
It cost the federal government about $2.3 billion in Medicare and other federal insurance costs, lost taxes and criminal justice expenses.
State of play: Georgia received $636 million in a settlement with major U.S. opioid distributors and a manufacturer.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
CBS News
20 minutes ago
- CBS News
Medicaid cuts could devastate hundreds of rural hospitals in GOP states, Democrats say
Cuts to federal spending on Medicaid could affect hundreds of rural hospitals in many states that have elected Republican senators and voted for President Trump, Senate Democrats warned Thursday, citing a list they commissioned of rural hospitals in financial distress. "If Republicans plan to pass drastic cuts to Medicaid and Medicare and effectively repeal the Affordable Care Act, communities should know exactly what they stand to lose," Sen. Ed Markey, the top Democrat in the Senate's health committee, said in a statement. The warning from Senate Democrats, outlined in a letter sent to President Trump and Republican congressional leaders, comes as senators are now wrestling with the budget package that Mr. Trump dubbed the "big, beautiful bill," which narrowly passed the House last month. Budget analysts say a slew of changes that the House bill made to Medicaid provisions — which backers argue would target "excesses and abuses" in the program — could add up to reduced federal Medicaid spending by more than $800 billion over the next decade, resulting in 7.8 million more uninsured people. The American Hospital Association has warned Medicaid cuts being considered by Congress "could have a devastating impact on rural hospitals," which often face larger shares of patients without health insurance. "Rural hospitals serve as critical — and sometimes the sole — source of care for rural communities," the hospital lobbying group says. Democrats cited a list of at-risk rural hospitals that the University of North Carolina's Cecil G. Sheps Center for Health Services Research compiled at their request. "If your party moves ahead with these drastic health care cuts that will cut millions of people off their health insurance coverage, rural hospitals will not get paid for the services they are required by law to provide to patients. In turn, rural hospitals will face deeper financial strain," the Democrats' letter states. The center analyzed data from the Centers for Medicare and Medicaid Services to compile a list of rural hospitals at the highest risk of financial distress, broken down by state and congressional district. "Republican health care cuts would be felt by rural hospitals across the country. In Louisiana, 32 rural hospitals — or a majority of rural hospitals in the state — are serving a high concentration of Medicaid patients. A total of 33 hospitals are at risk based on serving a high share of Medicaid patients, experiencing negative total margins, or both," Democrats wrote. Louisiana is the home state of Sen. Bill Cassidy, the top Republican on the Senate health panel. The letter also itemized rural hospitals at risk in Alaska, Kentucky, West Virginia, Alabama and Tennessee. "Substantial cuts to Medicaid or Medicare payments could increase the number of unprofitable rural hospitals and elevate their risk of financial distress. In response, hospitals may be forced to reduce service lines, convert to a different type of healthcare facility, or close altogether," wrote University of North Carolina researchers Mark Holmes, George Pink and Tyler Malone in their responses to the Democrats.
New York Post
20 minutes ago
- New York Post
Starbucks set to debut a new drink — packed with protein: ‘This thing is going to be a rocket'
Even Starbucks is hopping on the protein trend. If you've been on the internet in recent months, you've probably seen an increase in interest in protein-heavy food and drinks. Now, Starbucks is testing a new way to instantly add a whopping 15 grams of protein to nearly any beverage. The coffee giant is testing a protein cold foam at five locations in the US through its Starting Five program. It's part of CEO Brian Niccol's hopes to expand into the wellness category, the company announced during the Starbucks Leadership Experience in Las Vegas. 3 Starbucks is testing a protein cold foam at five locations in the US through its Starting Five program. Starbucks 'This thing is going to be a rocket,' Niccol said on stage in Las Vegas. 'It's on trend. It's delicious.' Niccol explained to Axios that the new innovation is geared toward a number of consumer groups, such as 20-year-old males, 50-year-old females and people taking GLP-1s. 'I was watching people coming to our stores, they would get three shots of espresso over ice,' Niccol explained. 'And in some cases, they pull their own protein powder out of their bag, or in other cases, they have a protein drink, like a Fair Life, and they'd pour that into their drink.' 'I'm like, well, wait a second, we can make this experience better for them,' he added. There's currently a huge push for protein with Gen Z, with different recipes and trends such as the '100 grams of protein daily' challenge going viral on TikTok. And with the continuous rise of GLP-1 drugs, research has shown that a high-protein diet is vital to maintaining muscle with the appetite-suppressing injectable treatments. 3 Starbucks shared that their protein powder should be able to be added to any of its cold foam flavors. Starbucks 'The good news is now I think we're right on trend, and we can do it, I think, arguably better than anybody else,' Niccol said. According to Fast Company, the protein cold foam will be identical to the cold foam Starbucks customers know and love — but it will be packed with somewhere between 15 and 18 grams of protein. The world's largest coffee chain reportedly initially imagined that the protein blend would simply mix into drinks, but it kept getting clumpy — something that protein powder consumers may know a thing or two about — and they wanted to solve that problem. 3 The protein cold foam will reportedly be packed with somewhere between 15 and 18 grams of protein. Dontree – The development team found that blending the powder into foam got rid of the clumps, which led to the protein cold foam innovation. Starbucks shared that their protein powder should be able to be added to any of its cold foam flavors, but the current testing version is a banana cold foam, FoodSided reported. They're starting the testing with Starbucks' Iced Caffe Latte. While it's being tested in just five locations at the moment, Niccol told Axios he thinks the nationwide release of the protein cold foam will be sooner rather than later. 'It's not one of those things that's years away. It's months away,' he said.
Yahoo
2 hours ago
- Yahoo
Opinion: It's Time to Buy UnitedHealth Group Stock After a 50% Plunge
Most of UnitedHealth Group's issues should be temporary. The two biggest threats to the healthcare giant are iffy. The price is right to buy UnitedHealth Group stock after its steep decline. 10 stocks we like better than UnitedHealth Group › UnitedHealth Group (NYSE: UNH) might want to change its stock ticker from "UNH" to "UGH." The latter better captures the feelings of the healthcare giant's shareholders in recent months. A string of problems has caused UnitedHealth Group's share price to plunge roughly 50% from the peak set in the fourth quarter of 2024. Some analysts have downgraded the stock, with HSBC recommending that investors reduce their holdings and slashing its price target. I have a different opinion, though. I think it's time to buy UnitedHealth Group stock. Here are three reasons why. I don't think investors should ignore UnitedHealth Group's issues. However, the challenges should be viewed with a long-term perspective. I suspect most of the problems the company faces should be temporary. UnitedHealth Group has already largely moved past the cyberattack that occurred in February 2024. Although it cost the healthcare company over $2 billion, that issue has already proven to be a short-lived one. Higher Medicare Advantage costs are the main culprit behind UnitedHealth Group's suspension of its 2025 full-year guidance. But the company says that it expects to return to growth in 2026. I believe this prediction because it makes sense. Insurers sometimes incur higher-than-anticipated costs and feel the pain for a while. However, once they adjust premiums, the problem goes away. UnitedHealth Group announced the sudden departure of former CEO Andrew Witty at the same time it withdrew its 2025 outlook. Any worries investors might have had surrounding this move probably dissipated quickly after they learned Stephen Hemsley was returning to run the company. Hemsley served as CEO from 2006 through 2017, a period when UnitedHealth Group stock more than tripled. I also view the two biggest threats to UnitedHealth Group as iffy. What are those threats? An alleged U.S. Department of Justice criminal investigation of the company and President Trump's stated goal to eliminate pharmacy benefits managers (PBMs). Noted that I used the word "alleged" to describe the U.S. Department of Justice probe. The Wall Street Journal reported on May 14, 2025, that "people familiar with the matter" revealed that the DOJ had launched a criminal investigation of UnitedHealth Group for possible Medicare fraud. However, the company quickly responded that it hadn't been notified of any DOJ investigation. That status hasn't changed. President Trump did announce that he wants to "cut out the middleman," a clear reference to PBMs. That's easier said than done, though, to put it mildly. Removing PBMs from the U.S. healthcare system would require a detailed, comprehensive plan that so far has not been provided. That plan would also have to pass in both the Senate and the House of Representatives. You can bet that the PBM industry, including UnitedHealth Group, would lobby fiercely against any such legislation. I think this threat, while serious, has a relatively low probability of actually materializing. Finally, I think all these issues are fully baked into UnitedHealth Group's share price. The stock currently trades at a forward price-to-earnings ratio of around 13.3. That's well below the S&P 500 healthcare sector forward earnings multiple of 16.6. It's also the lowest valuation for UnitedHealth Group in more than a decade. Could the stock fall further? Maybe, but I believe that UnitedHealth Group's share price has bottomed out. You might have noticed that UnitedHealth Group's share price has traded in a relatively narrow range since the steep decline in April and May. This trading pattern seems to confirm my view. Any good news for UnitedHealth Group could provide a nice catalyst. I predict that the company will have some positive developments in the not-too-distant future, potentially including new full-year guidance that calms investors. If I'm right, buying UnitedHealth Group stock now could pay off handsomely. Before you buy stock in UnitedHealth Group, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and UnitedHealth Group wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $649,102!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $882,344!* Now, it's worth noting Stock Advisor's total average return is 996% — a market-crushing outperformance compared to 174% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of June 9, 2025 HSBC Holdings is an advertising partner of Motley Fool Money. Keith Speights has no position in any of the stocks mentioned. The Motley Fool recommends HSBC Holdings and UnitedHealth Group. The Motley Fool has a disclosure policy. Opinion: It's Time to Buy UnitedHealth Group Stock After a 50% Plunge was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
